The deal underscores a broader shift in autoimmune drug development toward therapies that aim to reprogram disease-driving ...
The real “commercial launch” happens years before launch preparation officially begins. Once Phase III begins, your evidence ...
Teva's Honestly HD campaign, featuring Will Forte, aims to raise awareness about Huntington's disease through personal ...
AstraZeneca entered a strategic collaboration with CSPC Pharmaceuticals to expand its weight management and metabolic disease ...
In today’s Pharmaceutical Executive Daily, Public Citizen files suit over undisclosed drug pricing agreements involving ...
In today’s Pharmaceutical Executive Daily, MJH Life Sciences CEO, Mike Hennessy Jr. examines why pharma and medtech still ...
The US Department of Health and Human Services (HHS) issued new guidance clarifying how pharmaceutical manufacturers can ...
PE: After presenting topline results from Phase 3 trials, what's next for Varegacestat? Siegall: We presented topline data.
Seamless Therapeutics entered into a strategic global research collaboration and licensing agreement with Eli Lilly and ...
Public Citizen filed a lawsuit against the Trump administration in the U.S. District Court for the District of Columbia ...
Roche reported positive Phase II topline data showing that its once-weekly dual glucagon-like peptide-1 and glucose-dependent ...
If you want the cleanest case study of pharma and diagnostics actually operating as one strategic engine, it’s Roche. Roche ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results